Differential splice isoforms of mouse CDK2 play functionally redundant roles during mitotic and meiotic division

Nathan Palmer,S. Zakiah A. Talib,Jin Rong Ow,Tommaso Tabaglio,Christine M.F. Goh,Li Na Zhao,Ernesto Guccione,Kui Liu,Philipp Kaldis

DOI: https://doi.org/10.1101/2024.09.03.610967

2024-09-04

Abstract:In most mammals, the cell cycle kinase; cyclin-dependent kinase 2 (CDK2) is expressed as two major isoforms due to the inclusion or exclusion of an alternatively spliced exon. The shorter CDK2 isoform: CDK2S, is expressed constitutively during the cell cycle and can be detected in many different tissue types. In contrast, the longer isoform: CDK2L, shows preferential expression in meiotically dividing cells of the germ cells and upon S-phase entry during mitotic cell division. Both CDK2L and CDK2S form heteromeric complexes with cyclins A2 and E1 . However, complexes comprised of each isoform differ considerably in their kinase activity towards known CDK substrates. It is currently unknown whether the long and short isoforms of CDK2 play functionally different roles during either mitotic and meiotic divisions as conventional knockout methodology leads to the loss of both isoforms. In this study, we find that both CDK2L and CDK2S are sufficient to support both mitotic and meiotic division when expressed in the absence of the other. This data contributes to the explanation of the apparent tolerance of the evolutionary loss of CDK2L expression in humans.

Cell Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the functional roles of different splicing isoforms of CDK2 (cyclin - dependent kinase 2) in mitosis and meiosis. Specifically, the paper focuses on whether there are functional differences or redundancies between the two main isoforms of CDK2 - the shorter CDK2S and the longer CDK2L - in these key cellular processes. Since traditional knockout methods will lead to the simultaneous deletion of both isoforms, making it difficult to study their respective specific roles, the authors explored this problem by generating mouse models that express only one isoform. In this way, they hope to clarify the roles of these two isoforms in supporting normal cell division, especially in maintaining reproductive health, and whether there is functional complementarity or specificity between them.

The main findings of the paper show that, whether in mitosis or meiosis, the independent expression of CDK2S or CDK2L is sufficient to support the normal cell division process, which indicates that these two isoforms can compensate for each other in vivo, thus explaining the tolerance of CDK2L expression loss during human evolution. In addition, the study also reveals that CDK2L has a higher binding affinity for specific sites of telomeres in specific stages of meiotic prophase I (such as the formation of synaptonemal complexes), and this function can also be replaced by CDK2S in the absence of CDK2S. These results not only enhance our understanding of the roles of different CDK2 isoforms in cell cycle regulation, but also provide a basis for further exploring their conservation and variation among different species.